Zoetis is a global animal health company engaged in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests, and precision animal health solutions. It serves eight species — dogs, cats, horses, cattle, swine, poultry, fish, and sheep — across seven major product categories including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceuticals, and diagnostics.
The company operates in two segments: United States ($5.1 billion, 54% of 2025 revenue) and International ($4.3 billion, 45%). In the U.S., 83% of revenue derives from companion animals; internationally the split is 56% companion animal and 44% livestock. A Client Supply Services organization provides contract manufacturing to third parties. Originally a Pfizer business unit, Zoetis has a nearly 75-year heritage in animal health.
Total Geographical Area 50% · US 27% · Other Emerging Markets 5% · Other Developed Markets 3% · …
geographic · FY2025 (ended Dec 2025) · share of tagged segment revenue (10-K XBRL, as filed)
